Magazine Article | November 8, 2017

What Makes Roche's Approach To Partnering Unusual

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

Listening to Sophie Kornowski-Bonnet, Ph.D., talk about Roche’s approach to partnering is overwhelming. In her distinct French accent, she recounts anecdote after anecdote of a 30-year pharma career that spans not only multiple companies but multiple continents.

It’s no wonder she landed at Roche, a company rich with successful and long-running partnerships with companies such as Chugai Pharmaceutical. That commitment to partnering is even more evident when you notice that Kornowski-Bonnet, the company’s head of partnering, also serves on the senior leadership team — a rarity among top biopharma companies. That’s not the only fact, though, that could be considered unusual when talking about Roche’s approach to partnering.

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.